New Alcon Surveys Show Patients Have Fuzzy Understanding of Presbyopia; ECPs Agree

It’s Presbyopia Awareness Month and Alcon is on a mission to educate consumers about a condition that is expected to impact 123 million...

Read More

Novartis, Alcon Report Growth In Second Quarter of 2018

Both Novartis and Alcon reported that their net sales grew by 5%, while Alcon’s core operating income grew 14% Alcon’s net sales were USD 18...

Read More

Novartis Announces Intention to Spin Off Alcon

Novartis has announced that they intend to seek shareholder approval to spin off 100% of Alcon's eye care device business into a standalone,...

Read More

Novartis Delivered Solid 2016 Performance, Alcon Q4 Sales Flat

Sales were in line with last fiscal year due to strong performances from growth products (Cosentyx, Entresto, Gilenya, oncology, Sandoz...

Read More

Novartis on Alcon: All Options are Open

Reuters reported yesterday, that Swiss parent of Alcon, drugmaker Novartis is considering the sale of its eye care unit Alcon  The source is an...

Read More
1 3 4 5 6 7 13